Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
13.13
-0.02 (-0.15%)
At close: Sep 10, 2025, 4:00 PM
13.07
-0.06 (-0.46%)
After-hours: Sep 10, 2025, 5:11 PM EDT

Lyell Immunopharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
0.060.060.1384.6810.657.76
Upgrade
Revenue Growth (YoY)
11.11%-53.08%-99.85%695.15%37.31%1080.52%
Upgrade
Gross Profit
0.060.060.1384.6810.657.76
Upgrade
Selling, General & Admin
50.1252.0466.98117.3189.0646.88
Upgrade
Research & Development
166.47171.6182.95159.19138.69182.24
Upgrade
Other Operating Expenses
-5.39-4.65-4.3-4.86-3.53-1.65
Upgrade
Operating Expenses
211.21218.99245.63271.64224.22227.48
Upgrade
Operating Income
-211.15-218.93-245.5-186.96-213.57-219.72
Upgrade
Interest & Investment Income
18.0224.0723.457.051.175.94
Upgrade
Other Non Operating Income (Expenses)
1.040.891.851.890.11.53
Upgrade
EBT Excluding Unusual Items
-192.09-193.98-220.2-178.02-212.31-212.26
Upgrade
Gain (Loss) on Sale of Investments
-0.18-13-12.92-5-36.7-
Upgrade
Gain (Loss) on Sale of Assets
-5.09-1.34-1.51-0.1-1.214.88
Upgrade
Asset Writedown
-52.74-51.3----
Upgrade
Other Unusual Items
5.883.8---2.9
Upgrade
Pretax Income
-331.4-342.99-234.63-183.12-250.22-204.47
Upgrade
Net Income
-331.4-342.99-234.63-183.12-250.22-204.47
Upgrade
Preferred Dividends & Other Adjustments
-----3.58
Upgrade
Net Income to Common
-331.4-342.99-234.63-183.12-250.22-208.05
Upgrade
Shares Outstanding (Basic)
1413131271
Upgrade
Shares Outstanding (Diluted)
1413131271
Upgrade
Shares Change (YoY)
11.19%4.18%1.58%81.79%925.18%144.21%
Upgrade
EPS (Basic)
-23.52-26.23-18.70-14.82-36.82-313.85
Upgrade
EPS (Diluted)
-23.52-26.23-18.70-14.82-36.82-313.85
Upgrade
Free Cash Flow
-172-162.86-166.38-193.83-191.75-212.36
Upgrade
Free Cash Flow Per Share
-12.21-12.46-13.26-15.69-28.22-320.34
Upgrade
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
-351916.67%-358906.56%-188845.39%-220.77%-2005.31%-2832.92%
Upgrade
Profit Margin
-552328.33%-562285.25%-180486.15%-216.24%-2349.47%-2682.49%
Upgrade
Free Cash Flow Margin
-286661.67%-266980.33%-127984.62%-228.89%-1800.50%-2737.94%
Upgrade
EBITDA
-194.87-199.3-225.25-168.94-199.94-215.43
Upgrade
EBITDA Margin
----199.49%--
Upgrade
D&A For EBITDA
16.2819.6320.2518.0213.624.29
Upgrade
EBIT
-211.15-218.93-245.5-186.96-213.57-219.72
Upgrade
EBIT Margin
----220.77%--
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q